"Uveal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the UVEA.
Descriptor ID |
D014604
|
MeSH Number(s) |
C04.588.364.978 C11.319.494 C11.941.855
|
Concept/Terms |
Uveal Neoplasms- Uveal Neoplasms
- Neoplasm, Uveal
- Neoplasms, Uveal
- Uveal Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Uveal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Uveal Neoplasms".
This graph shows the total number of publications written about "Uveal Neoplasms" by people in this website by year, and whether "Uveal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 |
2000 | 1 | 0 | 1 |
2001 | 2 | 0 | 2 |
2003 | 1 | 0 | 1 |
2004 | 2 | 0 | 2 |
2007 | 1 | 0 | 1 |
2008 | 4 | 0 | 4 |
2009 | 1 | 1 | 2 |
2010 | 2 | 1 | 3 |
2011 | 4 | 1 | 5 |
2012 | 5 | 0 | 5 |
2013 | 4 | 2 | 6 |
2014 | 4 | 0 | 4 |
2015 | 1 | 0 | 1 |
2016 | 4 | 2 | 6 |
2017 | 7 | 0 | 7 |
2018 | 9 | 0 | 9 |
2019 | 7 | 0 | 7 |
2020 | 8 | 2 | 10 |
2021 | 4 | 0 | 4 |
2022 | 5 | 0 | 5 |
2023 | 4 | 0 | 4 |
2024 | 6 | 0 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Uveal Neoplasms" by people in Profiles.
-
COMPREHENSIVE MOLECULAR PROFILING OF UVEAL MELANOMA EVALUATED WITH GENE EXPRESSION PROFILING, PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA EXPRESSION, AND NEXT-GENERATION SEQUENCING. Retina. 2024 09 01; 44(9):1580-1589.
-
15-Gene Expression Profile and PRAME as Integrated Prognostic Test for Uveal Melanoma: First Report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1). J Clin Oncol. 2024 Oct; 42(28):3319-3329.
-
Re-treatment of locally recurrent uveal melanoma with repeat eye plaque I-125 brachytherapy: A single institution experience. Brachytherapy. 2024 Sep-Oct; 23(5):604-609.
-
Keratosis Pilaris-Like Reaction Associated With Chromatin Remodeling Complex Inhibition in Uveal Melanoma. JAMA Dermatol. 2024 Jun 01; 160(6):682-685.
-
GZ17-6.02 kills PDX isolates of uveal melanoma. Oncotarget. 2024 May 17; 15:328-344.
-
Utility of next-generation sequencing in the diagnosis of metastatic melanoma: A case report. J Cutan Pathol. 2024 Sep; 51(9):644-648.
-
Retrospective Analysis of Radiation-Induced Complications of Uveal Melanoma Patients Treated With Brachytherapy in the Era of Anti-VEGF. Am J Ophthalmol. 2024 04; 260:49-59.
-
Long-Read Sequencing Reveals Alternative Splicing-Driven, Shared Immunogenic Neoepitopes Regardless of SF3B1 Status in Uveal Melanoma. Cancer Immunol Res. 2023 12 01; 11(12):1671-1687.
-
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma. N Engl J Med. 2023 Dec 14; 389(24):2256-2266.
-
Overview of late complications of radiation therapy in uveal melanoma. Chin Clin Oncol. 2023 06; 12(3):29.